Demonstrates SDF-1α's role in altering mitochondrial dynamics in chondrocytes, suggesting potential OA therapies.
Mitochondrial quality control is crucial for maintaining chondrocyte homeostasis, and mitochondrial dysfunction is a key contributor to osteoarthritic (OA) pathogenesis. Reports have indicated that the level of SDF-1α increases during the progression of OA; however, its effects on mitochondrial dynamics in chondrocytes remain poorly understood. This study investigated the effects of SDF-1α on mitochondrial changes and its underlying molecular mechanisms. We found that SDF-1α reduced the number of mitochondria, caused the generation of many granular mitochondria via mitochondrial dynamics, and resulted in enhanced mitophagy in chondrocytes. SDF-1α activated AMPKα signalling and promoted its nuclear translocation to achieve these changes in mitochondria. Moreover, SDF-1α-induced mitochondrial changes require the participation of the receptor CXCR4, and the SDF-1α/CXCR4 regulatory axis increases cytoplasmic MAPK/ERK signalling to promote AMPKα-controlled mitochondrial changes. This study enhances our understanding of the role of SDF-1α in mitochondrial changes in chondrocytes and suggests the potential of therapeutic strategies for OA by targeting mitochondrial function.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: